SEC Contract Filing

Filing Date: 2024-03-25

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>tm249556d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit&nbsp;10.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>EXECUTION VERSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<IMG SRC="tm249556d1_ex10-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">United Therapeutics Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1000 Spring Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Silver Spring MD 20910</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: James Edgemond, Chief Financial Officer and Treasurer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Re: <U>Accelerated Share Repurchase</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This master confirmation
(this &ldquo;<U>Master Confirmation</U>&rdquo;), dated as of March&nbsp;25, 2024 is intended to set forth certain terms and provisions
of certain Transactions (each, a &ldquo;<U>Transaction</U>&rdquo;) entered into from time to time between Citibank, N.A. (&ldquo;<U>Citibank</U>&rdquo;)
and United Therapeutics Corporation (&ldquo;<U>Counterparty</U>&rdquo;). This Master Confirmation, taken alone, is neither a commitment
by either party to enter into any Transaction nor evidence of a Transaction. The additional terms of any particular Transaction shall
be set forth in a Supplemental Confirmation substantially in the form of <U>Annex A</U> hereto (a &ldquo;<U>Supplemental Confirmation</U>&rdquo;),
which shall reference this Master Confirmation and supplement, form a part of, and be subject to this Master Confirmation. This Master
Confirmation and each Supplemental Confirmation shall constitute a &ldquo;Confirmation&rdquo; as referred to in the Agreement specified
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The definitions and provisions
contained in the 2002 ISDA Equity Derivatives Definitions (the &ldquo;<U>Equity Definitions</U>&rdquo;), as published by the International
Swaps and Derivatives Association,&nbsp;Inc., are incorporated into this Master Confirmation. This Master Confirmation and each Supplemental
Confirmation evidence a complete binding agreement between Counterparty and Citibank as to the subject matter and terms of each Transaction
to which this Master Confirmation and such Supplemental Confirmation relate and shall supersede all prior or contemporaneous written
or oral communications with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Master Confirmation
and each Supplemental Confirmation supplement, form a part of, and are subject to an agreement in the form of the ISDA 2002 Master Agreement
(the &ldquo;<U>Agreement</U>&rdquo;), as if Citibank and Counterparty had executed the Agreement on the date of this Master Confirmation
(but without any Schedule except for the election of New York law (without reference to its choice of laws doctrine other than Title
14 of Article&nbsp;5 of the New York General Obligations Law) as the governing law and US Dollars (&ldquo;<U>USD</U>&rdquo;) as the Termination
Currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transactions shall be
the sole Transactions under the Agreement. If there exists any ISDA Master Agreement between Citibank and Counterparty or any confirmation
or other agreement between Citibank and Counterparty pursuant to which an ISDA Master Agreement is deemed to exist between Citibank and
Counterparty, then notwithstanding anything to the contrary in such ISDA Master Agreement, such confirmation or agreement or any other
agreement to which Citibank and Counterparty are parties, the Transactions shall not be considered Transactions under, or otherwise governed
by, such existing or deemed ISDA Master Agreement, and the occurrence of any Event of Default or Termination Event under the Agreement
with respect to either party or any Transaction shall not, by itself, give rise to any right or obligation under any such other agreement
or deemed agreement. Notwithstanding anything to the contrary in any other agreement between the parties or their Affiliates, the Transactions
shall not be &ldquo;Specified Transactions&rdquo; (or similarly treated) under any other agreement between the parties or their Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 1